Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-081069
Filing Date
2025-06-03
Accepted
2025-06-03 16:58:12
Documents
2
Period of Report
2025-05-27

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1690
2 EX-24.1 nams-ex24_1.htm EX-24.1 20540
  Complete submission text file 0000950170-25-081069.txt   23745
Mailing Address C/O NUPATHE, INC. 227 WASHINGTON STREET, SUITE 200 CONSHOHOCKEN PA 19428
Business Address
Marino Michael F III (Reporting) CIK: 0001502700 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41562 | Film No.: 251020542

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Issuer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)